Insights On Outsourced Drug Development

  1. Little Patients, Big Challenges: Developing Pediatric Formulations 5/12/2025

    Explore the development of high-quality, child-friendly oral formulations, as well as learn about new testing requirements for impurities and innovative approaches to creating age-appropriate medications.

  2. Improving In Vitro Cancer Modeling 8/2/2024

    Organ-on-a-Chip technology represents a significant advancement in drug discovery. By mimicking human physiology, Organ-Chips can enhance the predictive accuracy of preclinical models and accelerate drug development.

  3. Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency 9/25/2025

    Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.

  4. How Adept Formulation Helps Overcome Manufacturability Challenges 6/17/2026

    Initial development, scaleup, and tech transfer of complex multi-particulate drug systems requires meticulous planning to mitigate manufacturing risks.

  5. Improving Swallowing And Palatability With Patient‑Friendly Forms 1/15/2026

    Improve medication adherence and health outcomes by developing patient-friendly dosage forms that enhance swallowability and palatability for pediatric, geriatric, and dysphagic populations.

  6. Accelerate FDA Approval With Fast Track Designation 7/3/2025

    Learn how Fast Track Designation streamlines the FDA review process and offers faster approval for serious diseases or life-threatening conditions.

  7. Assessment Of Compound Toxicity Effects With High-Content Imaging 3/17/2025

    3D cellular models and bioprinting enhance drug safety predictions and offer precise spatial control. Explore an automated method for generating liver models to improve reproducibility and reliability in toxicity testing.

  8. Drug Substance For Early Clinical Phase Initiation 5/6/2026

    Explore how proactive nitrosamine impurity risk assessment protects early clinical drug supply, minimizes development delays, and enables confident progression to first‑in‑human studies.

  9. How Isogenic Organ-Chips Are Transforming The Future Of Research 6/25/2026

    Modeling the human brain requires more than simplified systems. New approaches that incorporate diverse cell types are improving how researchers study neurovascular function with greater precision.

  10. Bridging The Gap Between Traditional Models And Human Biology 9/3/2024

    Whether you are new to Organ-on-a-Chip technology or seeking to expand your expertise, watch to gain the knowledge and insights needed to effectively implement this technology into your research.